Table 2.
NETRIN1-PRS |
Genomic-PRS |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Effect Size, β | SD | t Value | p Value | p Value, FDR Corrected | R2a | Effect Size, β | SD | t Value | p Value | p Value, FDR Corrected | R2a | |
gFA | −.026 | .012 | −2.197 | .028 | .056 | .068 | −.033 | .012 | -2.769 | .006 | .011b | .109 |
Association Fibers | −.033 | .012 | −2.762 | .006 | .023 | .107 | −.034 | .012 | -2.836 | .005 | .011 | .113 |
Thalamic Radiations | −.018 | .012 | −1.482 | .138 | .185 | .032 | −.022 | .012 | -1.855 | .064 | .064 | .050 |
Projection Fibers | −.011 | .012 | −0.904 | .366 | .366 | .012 | −.029 | .012 | -2.415 | .016 | .021b | .083 |
FDR, false discovery rate; Genomic-PRS, polygenic risk score derived from the whole genome, excluding NETRIN1 pathway genes; gFA, global fractional anisotropy; NETRIN1-PRS, polygenic risk score derived from the NETRIN1 signaling pathway; PRS, polygenic risk score.
R2 is the estimate of variance explained by each pathway, in %.
Statistically significant p value after false discovery rate correction.